Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-678-2 | CAS number: 86-52-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Exposure related observations in humans: other data
Administrative data
- Endpoint:
- exposure-related observations in humans: other data
- Type of information:
- other: case report on accidental skin exposure
- Adequacy of study:
- key study
- Study period:
- From April 20, 1994 to date of publication September 30, 1997
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- publication
- Title:
- An Erythema Multiforme-like Eruption Caused by Exposure to 1-Chloromethylnaphthalene
- Author:
- Shoko Urano and Yoshiki Tokura
- Year:
- 1 998
- Bibliographic source:
- The Journal of Dermatology
Materials and methods
- Type of study / information:
- Case report of accidental percutaneous exposure to 1-Chloromethylnaphthalene.
- Endpoint addressed:
- skin irritation / corrosion
- skin sensitisation
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Human experience in occupational setting. A case report of young male patient with accidental cutaneous exposure of his left leg to 1-Chloromethylnaphthalene. Immediately after the exposure he took off his clothes and washed his left leg with much water and treated himself with topical gentamycin sulfate. Directly after the expossure he felt a burning sensation and developed erythema and erosion on his left thigh. The lesion improved considerably over the following 5 days. But 3 days later a burning sensation and a new eruption occured, which quickly spread to his right tigh and the forearms.
- GLP compliance:
- no
Test material
- Specific details on test material used for the study:
- Crude 1-chloromethylnaphthalene (1-CMN), not further specified and gentamycin sulfate
Method
- Ethical approval:
- not applicable
- Details on study design:
- This is a human experience in occupational setting (on April 12, 1994). A case report of young male patient with accidental cutaneous exposure of the left leg to 1-Chloromethylnaphthalene and following an erythema multiforme-like reaction appeared on the right tigh and on both forearms
Human male patient:
- Accidental percutaneous exposure of left leg during 1-CMN purification process, one exposure level (concentration and amount of exposure not described).
- Admission to the hospital on April 20, 1994 and start of observation
- elevated liver tranyaminase levels
- reduced tear production
- after 8 weeks normal levels of all changed parameters - Exposure assessment:
- not specified
- Details on exposure:
- Accidental cutaneous exposure of left leg during 1-CMN purification process (April 12, 1994). One exposure level (concentration and amount of exposure not described). No time specification of exposure given. The patient took off his clothes immediately after the exposure and washed his left leg with much water. Patient treated himself with topical antibiotics (gentamycin sulfate).
Results and discussion
- Results:
- Accidental cutaneous exposure in young male patient caused erythematous and necrotic skin changes (following the initial skin change of the primary irritant contact dermatitis). Systemic manifestations of high fever, liver involvement and tear insufficiency developed. Mechanism for developing a "systemic" erythema multiforme-like eruption from topical agent remains unclear.
Any other information on results incl. tables
Accidental percutaneous exposure/young male patient:
- immediately after exposure (took clothes off and washed leg with much water) patient felt burning sensation and developed erythema and erosion on left thigh
- treatment with topical antibiotics (gentamycin sulfate) and lesion improved considerably over the following five days
- one week after exposure, the patient noticed a burning sensation and a new eruption on his left thigh, which quickly spread to the right thigh and the forearms
- on admission to hospital (8 days after exposure)- body temp. 38.5°C, diffuse erythematous plaques with multiple small vesicles on left thigh and multiple vesicular erythematous lesions on right thigh and bilateral forearms
- laboratory studies of urinanalysis, ASLO, rheumatoid factor, hepatitis B antigen, hepatitis C antibody, fluorescent antinuclear antibodies were either within normal limits or negative
- patient was treated with 30 mg Prednisolone per day, however erythematous lesions spread and became confluent on both thigh, vesicular erythematous lesions developed on forearms and dorsa of hands
- on third day after admission-histological examination of vesicular lesion on right forearm revealedheavy infiltration of mononuclear inflammatory cells
- Serum transaminase level elevated one week after exposure to 1-CMN and lasted for two month. Such elevation is more likely caused by an allergic reaction to 1 -CMN than by its toxic reaction.
- Prednisolon and Methylprednisolon therapy stoped spreading of erythematous lesions. Epithelization of denuded areas were almost completed 20 days after admission to the hospital.
- dry eyes and insufficiency of tear secretion 2 weeks after admission
Applicant's summary and conclusion
- Conclusions:
- 1-chloromethylnaphthalene (crude during purification process) may cause Erythema multiforme-like eruptions to the skin, high fever, reduced tear secretion and elevated liver transaminase levels.
After a treatment with methylprednisolone all changed parameters returned to normal within 8 weeks. - Executive summary:
Accidental percutaneous exposure of young male patient (left leg) to 1- chloromethylnaphthalene caused erythematous skin changes. The male patient showed systemic effects. Systemic manifestations of high fever, liver involvement and tear insufficiency developed.
After treatment with prednisolone and methylprednisolone the erythema vanished and the epithelization of the denuded areas was completed after 20 days. The patient was discharged from hospital one month after admission. After 8 weeks all changes returned to normal.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.